Big Pharma's Cynical Bet on Open Protein AI to Escape Google's Grip
Big Pharma hates relying on Google as much as academics do. They're pouring cash into open protein-folding AI—but don't call it altruism.
⚡ Key Takeaways
- Big Pharma funds OpenFold to avoid Google DeepMind dependency, not pure altruism.
- OpenFold provides full code and data, countering AlphaFold's restrictions.
- Skeptics predict pharma will steer open tools toward proprietary gains.
🧠 What's your take on this?
Cast your vote and see what theAIcatchup readers think
Worth sharing?
Get the best AI stories of the week in your inbox — no noise, no spam.
Originally reported by Understanding AI